Future Medicine Co., Ltd. (XKON: 341170)
1,900.00
0.00 (0.00%)
At close: Sep 10, 2024
Future Medicine Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|
Period Ending | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 4,410 | 3,220 | 4,471 | 3,163 |
Short-Term Investments | 1,000 | 3,054 | 3,000 | - |
Cash & Short-Term Investments | 5,410 | 6,273 | 7,471 | 3,163 |
Cash Growth | - | -16.03% | 136.18% | - |
Accounts Receivable | 0 | 0 | -0 | 14.85 |
Other Receivables | 78.35 | 83.77 | 119.28 | 0.39 |
Receivables | 78.35 | 83.77 | 119.27 | 15.24 |
Prepaid Expenses | 311.94 | 344.51 | 43.42 | 93.63 |
Other Current Assets | 11.34 | 8.66 | 2.62 | 11.62 |
Total Current Assets | 5,812 | 6,710 | 7,636 | 3,284 |
Property, Plant & Equipment | 599.93 | 671.81 | 769.28 | 895.61 |
Long-Term Investments | 483 | 143 | 143 | 143 |
Other Intangible Assets | 567.95 | 612.16 | 364.56 | 199.74 |
Long-Term Accounts Receivable | -0 | -0 | - | -0 |
Other Long-Term Assets | 201.22 | 201.22 | 191.83 | 322.61 |
Total Assets | 7,664 | 8,339 | 9,105 | 4,845 |
Accrued Expenses | 51.42 | 49.14 | 32.69 | 28.1 |
Short-Term Debt | - | - | 6,834 | - |
Current Portion of Leases | 153.29 | 157.25 | 150.14 | 124.32 |
Current Unearned Revenue | - | 7.51 | 7.51 | - |
Other Current Liabilities | 399.51 | 375.76 | 14,592 | 5,499 |
Total Current Liabilities | 604.22 | 589.67 | 21,617 | 5,651 |
Long-Term Debt | - | - | 1,900 | 8,626 |
Long-Term Leases | 72.98 | 106.42 | 222.01 | 336.08 |
Other Long-Term Liabilities | 222.22 | 221.68 | 75 | -0 |
Total Liabilities | 1,142 | 1,160 | 23,923 | 14,853 |
Common Stock | 4,638 | 4,638 | 3,413 | 1,517 |
Additional Paid-In Capital | 48,379 | 48,379 | 11,854 | 11,383 |
Retained Earnings | -48,086 | -46,922 | -33,897 | -23,395 |
Comprensive Income & Other | 1,591 | 1,083 | 645.69 | 486.46 |
Total Common Equity | 6,522 | 7,178 | -17,985 | -10,009 |
Shareholders' Equity | 6,522 | 7,178 | -14,818 | -10,009 |
Total Liabilities & Equity | 7,664 | 8,339 | 9,105 | 4,845 |
Total Debt | 226.27 | 263.67 | 9,106 | 9,087 |
Net Cash (Debt) | 5,184 | 6,010 | -1,635 | -5,924 |
Net Cash Per Share | 635.00 | 795.88 | -252.66 | -976.37 |
Filing Date Shares Outstanding | 9.28 | 9.28 | 6.83 | 6.07 |
Total Common Shares Outstanding | 9.28 | 9.28 | 6.83 | 6.07 |
Working Capital | 5,207 | 6,121 | -13,981 | -2,367 |
Book Value Per Share | 703.11 | 773.88 | -2634.67 | -1649.72 |
Tangible Book Value | 5,954 | 6,566 | -18,350 | -10,208 |
Tangible Book Value Per Share | 641.88 | 707.88 | -2688.07 | -1682.65 |
Machinery | 625.29 | 623.67 | 498.08 | 412.27 |
Source: S&P Capital IQ. Standard template. Financial Sources.